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Infection of poultry with chicken anemia virus (CAV) is implicated in several field problems in broiler flocks due to
the immunosuppression generated and, consequently, the increased susceptibility to secondary infections. Recently,
we have reported an increased occurrence of clinical cases caused by CAV strains distantly related to those
commonly used for vaccination. In order to understand the behavior of two Argentinean CAV strains (CAV-10 and
CAV-18) in two-week-old chickens, an immune and histopathological study was performed. Neither mortality nor
clinical signs were observed in the infected or control groups. Thymus lobes from chickens infected with both CAV
viruses were smaller compared to the negative control group. At 14 days post-infection (dpi), only chickens
inoculated with CAV-10 show a severe depletion of lymphocytes in the thymus cortex and in follicles from the
bursa of Fabricius. Also thymopoiesis disorders, such as reduction in the percentage of total DP (CD4 + CD8α+)
thymocytes and alteration in the percentages of DP subpopulations, were more important in animals inoculated
with the CAV-10 than the CAV-18 strain. In addition, only animals infected with CAV-10 show a decrease in CD8αβ
splenocytes. Altogether our results show that, although both Argentinean CAV strains produce subclinical infections
in chickens causing immunosuppression at 14 dpi, they might differ in their in vivo pathogenicity.Introduction
Chicken anemia virus (CAV) is a closed circular negative
single-stranded DNA virus [1] from the Circoviridae
family that belongs to the Gyrovirus genus [2]. The virus
genome encodes a polycistronic mRNA from which three
viral proteins are translated [3,4]: ORF1 encodes VP1,
the only capsid protein; ORF2 encodes VP2, a scaffold
protein which allows the proper folding of VP1 [5,6];
and ORF3 encodes VP3, which is known as an apoptin
that induces apoptosis of thymocytes after in vivo infec-
tion and apoptosis of transformed avian cell lines after
in vitro infection [7,8].* Correspondence: rimondi.agustina@inta.gob.ar
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unless otherwise stated.Worldwide, CAV causes considerable economic losses
in the poultry industry because it is responsible for a
clinical disease with high mortality characterized by
anemia, haemorrhages and atrophy of the thymus and
bone marrow in young chicks [9]. Infection of chickens
older than two weeks of age, although considered subclin-
ical, also has immunosuppressive effects with important
consequences on growth and profitability of poultry
[10-12]. Markowsky-Grimsrud and Schat [13] have dem-
onstrated that experimental infection with CAV also
impairs the generation of pathogen-specific cytotoxic
T lymphocytes (CTL) that may have important impli-
cations for adaptive cell-mediated immunity to several
secondary pathogens. This was also observed by other
authors that reported secondary infections with other
viruses, bacteria, parasites and/or fungi [1,14-16].
Experimental infection of chickens with CAV induced a
substantial but transient decrease in some immunological
parameters corresponding to a generalized lymphocytopenial Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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14 days post-inoculation (dpi) and complete recovery at
28 dpi. These observations were observed in 1 or 14-day-
old inoculated chickens [19,20]. While there is a consen-
sus on the idea that absolute numbers of thymic lympho-
cytes dramatically decrease during the period of transient
leukopenia [19-21], the selective alterations in the percent-
ages of T lymphocyte subpopulations in the spleen during
the acute phase is still under discussion. Coud et al. [19]
showed a greater depletion of CTL than T-helper lympho-
cytes (ThL) in the spleen at 14 dpi, while Hu et al. [20]
showed no selective decrease of ThL or CTL by flow cyto-
metric analysis of CD4+ and CD8+ subpopulations. On
the contrary, Vaziry et al. [21] showed a reduction in the
percentage of CD4+ splenocytes only at 7 and 28 dpv, with
a simultaneous increase in the percentages of CD8+ cells.
It is noteworthy that most experimental infections with
CAV have been done with reference strains such as CIA-1
or Cux-1 [19-24]; therefore, knowledge of the pathogen-
icity of CAV field strains remains poor and needs to be
studied more.
In 2009, our group reported the circulation of CAV af-
fecting both broilers and layers in commercial flocks in
Argentina [25]. Sequence analysis of predicted VP1 pep-
tides showed that most of the Argentinean viruses have
a glutamine residue at positions 139 and 144, suggesting
that these viruses might have a reduced spread in an
avian lymphoblastoid cell line (MDCC-MSB1) compared
with Cux-1 [26]. We showed that the circulation of CAV
in commercial poultry in Argentina clearly affect their
immune status through a subclinical infection [25]. There-
fore, it would be important to broaden and deepen our
knowledge about the effect of subclinical experimental in-
fections with Argentinean CAV strains in chickens, more-
over considering the high frequency of clinical cases and
despite the fact that vaccination against CAV is common
in breeder flocks in Argentina.
The present study addresses the effect of subclinical in-
fection with two Argentinean CAV strains at 14 dpi. We
studied the percentage of T-lymphocyte subpopulations in







CAV-VP3 Rv 5′- TTACAGTCTTATACACCTTCTTGCG
CAV-Sec1 Rv 5′-AACGTCACTTTCGCAACGT-3′
CAV-Sec4 Fw 5′-AGGGCAACGTTCAGTTTCTA-3′
aGenBank accession no. M55918.produced in the thymus and bursa of Fabricius by both
viruses. In addition, this paper contains the first two
complete genome sequences of CAV published from
Argentinean field strains and the first report of the be-
haviour of these viruses in vivo.
Materials and methods
Amplification and sequencing of the CAV genome
Firstly, a pair of primers was designed to obtain the
complete genome of CAV (Table 1): CAV-NheI Fw and
CAV-NheI Rv. The primers were used under cycling
conditions of denaturation (5 min 95 °C), followed by 35 cy-
cles of denaturation (30 s 95 °C), annealing (30 s 54 °C) and
extension (5 min 72 °C). After a final extension (10 min
72 °C), samples were held at 16 °C, until visualization in a
1% agarose gel with ethidium bromide.
PCR products were purified with a QIAquick PCR
purification kit (Qiagen) and sequencing was performed
using the BigDye Terminator v3.1 Cycle Sequencing Kit
on an ABI PRISM 3700 DNA Analyzer (Applied Biosystems)
according to the manufacturer’s instructions. Sequences
were carried out with the same amplification primers and
internal primers CAV1, CAV2, CAV-VP1-A fw, CAV-
VP1-A rev, CAV-VP1-B fw and CAV-VP1-B rev previ-
ously described [25,27]. Six new additional internal
primers were designed to obtain the complete CAV
genome through overlapping fragments: CAV-Genome
Fw, CAV-Genome Rv, CAV-VP2 Fw, CAV-VP3 Rv,
CAV-Sec1 Rv and CAV-Sec4 Fw (Table 1).
The consensus amino acid and nucleotide sequences
for both CAV genomes were generated using Megalign
(DNASTAR, Madison, WI, USA). Sequences were as-
sembled and edited with Lasergene 8.1 (DNASTAR);
BioEdit 7 was used for alignment and residue analysis.
Chickens and housing
Specific-pathogen-free (SPF) White Leghorn embryonated
eggs free of CAV antibodies were purchased (Rosenbusch
S.A. CABA, Argentina), incubated and hatched in an
automatic incubator (Yonar, CABA, Argentina) under
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ately in sterilized isolators for chickens under negative
pressure conditions (Allentown CH8ISOL) with food
and water ad libitum throughout the experimental
period. Animal care and experimental procedures were
performed in accordance with the approved protocols
of the National Institute of Agricultural Technology
Ethics Committee (INTA, Argentina).
Viruses and inocula
The Argentinean CAV-10 and CAV-18 viruses were ob-
tained from commercial broilers in 2007 with increase of
mortality, gangrenous dermatitis and thymus and bursa
atrophy [25]. These strains were unable to be grown in
MDCC-MSB1 cells. Therefore, under our experimental
conditions, inocula were adjusted to 106 copies of CAV
DNA per animal for comparative analyses of our results.
Argentinean CAV viruses were propagated in chickens
and CAV inocula were prepared from thymus samples as
previously described [28]. Next, DNA was obtained with
the QIAamp DNA Mini Kit (Qiagen Inc.Valencia, CA,
USA) according to the manufacturer’s instructions, and
the number of CAV genomes contained in each inoculum
was determined by SYBR Green-based real-time quantita-
tive PCR (RT-qPCR). Values were converted to number of
copies of CAV DNA per μL of inoculum. Finally, the inoc-
ula were adjusted to 1 × 106 copies of CAV DNA/200 μL.
Quantitative Real Time PCR
SYBR Green-based quantitative real-time PCR (RT-qPCR)
was used to determine the number of copies of the CAV
genome in inocula.
Reagents
CAV DNA was amplified using reagents and primers
purchased from Biodynamics. (CABA, Argentina). Primers
used amplify a fragment (75 bp) located within the over-
lapping region between ORF2 and ORF3 (Table 2). The
primers were designed and evaluated using Primer Ex-
press v1.0 software. Individual PCR reactions, containing
15 pmol of each primer in a total volume of 25 μL, were
performed in an ABI Prism 7500 SDS system (Applied
Biosystems, Warrington, UK).
Cycling parameters
The cycling parameters consisted of the following steps:
95 °C hold for 10 min, followed by 40 cycles consisting of
denaturation at 95 °C for 15 s and annealing/extension atTable 2 Primers used in quantitative real time PCR to detect
Primer Sequence
CAV-Real Time Fw 5′-AGAGAGATCCGGATTGGTATCG
CAV-Real Time Rv 5′-TGGGAGCGCGAGCATT-3′
aGenBank accession no. M55918.50 °C for 1 min, and finally adding a dissociation melting
curve analysis.
Preparation of standards
A fragment of 75 bp of the CAV genome from Cux-1
vaccine strain was amplified by PCR using the primers
described in Table 2 and cloned in pGEM T-Easy vector
(Promega Madison, USA) to generate standard curves
for the quantitation of number of copies of CAV DNA.
Fresh tenfold dilutions were made from the plasmid
stocks in distilled water for each PCR run to avoid the
problem of plasmid degradation over time in the higher
dilutions. Cycle threshold (CT) values were used to plot
a standard curve and a range from 101 to 106 copy num-
bers was represented in each standard curve. The copy
number was determined using the conversion factor: 1
ug of a 1-kb DNA = 3.03 pmol ends [29].
Analysis
The results from the PCR experiments were analyzed
using Sequence Detection Systems v.1.6.3 software. The
default settings of the program were used to define both
the threshold value and baseline parameters for analysis
of the raw data. A standard curve was generated in each
assay and used to extrapolate the amounts in the un-
known samples.
Experimental design
Six two-week-old chickens were intramuscularly inocu-
lated with 200 μL of CAV-10 or CAV-18 containing 1 ×
106 CAV DNA copies. Negative control group (n = 6)
was inoculated with 200 μL of phosphate-buffered-saline
(PBS). Signs of anorexia, weakness, stunting, cyanosis, pe-
techiae and ecchymoses were looked for everyday in every
bird. Fourteen days after inoculation, chickens were bled,
euthanized and body, thymus, spleen and bursa of Fabri-
cius were weighed and recorded in all birds. From each
animal, the bursa and the first right lobe of the thymus
were separated for histopathological evaluation. Fractions
of the thymus and spleen were also kept for flow cytome-
try evaluation.
Histopathology
Samples of the thymus and bursa of Fabricius were col-
lected and immersed into 10% neutral buffered formalin
for fixation. Samples were dehydrated and embedded in
paraffin wax in the usual manner, sectioned (4 μm thick)
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Single cell suspensions from spleens were obtained by
direct mechanical disruption in RPMI 1640 through a
40 μm mesh (Cell Strainer, BD). Thymuses were cut into
very small pieces and mechanically disrupted by pressing
with a syringe plunger, in RPMI 1640. Then, cellular sus-
pensions were passed through a 40 μm mesh (Cell
Strainer, BD). Mononuclear cells were isolated from both
suspensions by centrifugation over Histopaque density
gradient (1.077 g/mL; Sigma, St. Louis, MO, USA) at
400 × g for 30 min and room temperature. Cells were
isolated from the interface, washed, and live cells were
counted using trypan blue exclusion.Flow cytometry analysis
Cells were diluted in staining buffer (PBS 1×, 10% FBS,
0.1% Sodium Azide) and 1 × 106 cells per well were
transferred into 96 well-plates (V-shape), and washed
twice with the same buffer. Staining was performed by
resuspending the cellular pellet of each well with 100 μL
of staining buffer including different combinations of
antibodies, or as single-color stainings for compensa-
tion. Cells were incubated at 4 °C for 30 min and washed
twice with staining buffer by centrifugation at 250 × g
for 5 min.
Avian monoclonal antibodies (mAbs) (CD3-SPRD,
CD4-FITC, CD8α-PE, CD8α-FITC and CD8β-PE) were
purchased from Southern Biotech (Birmingham, AL,
USA). Mononuclear cell suspensions from every thymus
and spleen were stained with one and two mAb mix, re-
spectively: CD3-SPRD, CD4-FITC and CD8α-PE in tube
A (for thymocytes and splenocytes), and CD3-SPRD,
CD8α-FITC and CD8β-PE in tube B (splenocytes). All
antibodies were titrated in order to determine the opti-
mal staining concentration of each one.
Positive cells were analyzed with a FACS Calibur flow
cytometer (BD Biosciences, San Jose, CA, USA) and
CellQuest software. Analysis was done on 20 000 events
and discrete viable lymphoid cell populations were gated
according to the forward/side scatter characteristics. Per-
centages of different lymphoid cell subpopulations in the
thymus and spleen were determined by multiparametric
analysis.Statistical analysis
Data were tested for normal distribution prior to analysis
(Shapiro-Wilk test) using the Statistical Package for the
Social Sciences for Windows (SPSS, version 15.0, Chicago,
IL, USA). An ANOVA test was used, and a Tukey’s test
was applied when differences were detected. Variables that
did not fit the ANOVA’s assumptions were analyzed
by Kruskall-Wallis and Bonferroni-Dunn post hoc test.
P-values of p < 0.05 were considered statistically significant.Serology
Sera were tested by competitive enzyme-linked immuno-
sorbent assay (ELISA) for specific antibodies against
CAV according to the manufacturer’s recommendations
(Idexx Laboratories, Inc., Westbrook, ME, USA) using
10-fold dilutions of each serum sample.
Nucleotide sequence accession numbers
The nucleotide genome sequence from Argentinean CAV
strains obtained in this study are available from GenBank
under accession numbers KJ872513 (CAV-10) and
KJ872514 (CAV-18).
Results
Characterization of CAV field strains used for
experimental infection of chickens
The complete nucleotide genome sequence of CAV-10
and CAV-18 was determined using primers described in
Table 1. Both Argentinean CAV genomes are 2298 nt
long, and lacked a 21-nt region located within the non-
coding, transcription-regulatory region of the genome
[4,30] that is present in the Cux-1 isolate (M55918). A
comparison between the two Argentinean CAV viruses
shows 14 individual nucleotide sequence differences dis-
persed throughout the genome, with three being located
in the non-coding region and the rest along ORF1. Nu-
cleotide differences between VP1 from CAV-10 and
CAV-18 resulted in only 2 amino acid changes, one
Q294H and the other S370T. In addition, both viruses
present a glutamine (Q) residue at positions 139 and 144
of VP1.
Clinical signs
No mortalities occurred after CAV or PBS inoculation
during the experiment. No clinical signs of disease and
no differences in body weight were observed between
CAV-inoculated and negative control groups.
Macroscopic alterations
Chickens inoculated with CAV-10 or CAV-18 show red-
dened and atrophied thymic lobes distributed on both
sides along the neck. In contrast, the control group had
whitish and firm thymic lobes (Figure 1). There were no
other significant gross lesions in any of the groups.
Mean thymus-to-body weight ratios were reduced
(p < 0.05) in both CAV-inoculated groups in comparison
to the negative control group (Figure 2). In addition, these
reductions were significantly different between CAV-10
and CAV-18 inoculated chickens. Spleens and bursas
did not significantly alter their weight at this time post-
infection.
Lymphocytes from mononuclear single cell suspensions
from thymuses and spleens were counted using trypan
blue exclusion, and cell depletion, expressed as the ratio
Figure 1 Gross lesions after 14 days post-infection with Argentinean CAV strains in 2-week-old chickens. Note that the thymic lobules
from CAV-10 (b) and CAV-18 (c) inoculated chickens are smaller and reddened than those from the control group (a).
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was analyzed in both organs. A significant reduction of
cell counts was observed in the thymuses from chick-
ens inoculated with CAV strains as shown in Figure 3
(p < 0.05).
Histopathological changes
On the one hand, thymuses from chickens inoculated
with CAV-10 experienced severe lymphocyte depletion
in the cortex (Figure 4b), showing a reduced demarca-
tion between the medulla and cortex. Large lympho-
blasts with karyomegaly and vacuolization of reticular
cells were also observed in thymuses from CAV-10 inoc-
ulated chickens, producing a starry-sky appearance.
Moreover, atrophy with moderate lymphoid depletion of
the lymphoid follicles was observed in bursae from birds











































Figure 2 Macroscopic alterations in chickens associated with chicken
(a), spleen-to-body weight ratios (b) and bursa-to-body weight ratios (c) fo
expressed as the mean (SD) from each group, n = 6. *p < 0.05 vs. Control; #and plasma cell infiltration were observed in some of
these bursae. On the other hand, thymus and bursa from
CAV-18 inoculated chickens did not show histopatho-
logical changes at 14 dpi.
Analysis of thymic cell subpopulations
To verify whether Argentinean CAV strains induce dis-
orders in lymphoid cell populations or not, the percent-
ages of different lymphoid subsets in thymuses from
CAV-inoculated chickens were compared to those from
control birds in gate 1 (G1) according to forward/side
scatter parameters. Thymocytes in G1 were divided into
small (G2) and large (G3) cells to verify if thymopoiesis
was also altered by CAV infection (Figure 5a).
Although the comparison of the lymphocyte percent-
ages from each group shows no significant differences in






















infectious anemia. Alterations of thymus-to-body weight ratios
llowing infection with CAV-10 or CAV-18, 14 dpi. The results are
p < 0.05 vs. CAV-18.
A B
Figure 3 Lymphocyte depletion after infection with Argentinean CAV strains. Lymphocyte depletion expressed as the ratio of cells/g of
thymus (A) or spleen (B) at 14 dpi in SPF chickens inoculated with CAV-10, CAV-18 or PBS at 2 weeks of age. The results are expressed as the
mean (SD) from each group, n = 6. *p < 0.05 vs. Control.
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portant reduction in the percentages of lymphocytes in
G2 from chickens inoculated with Argentinean CAV vi-
ruses (p < 0.05). In addition, CAV-10 show a higher reduc-
tion of lymphocytes in G2 than CAV-18 (p < 0.05). In
contrast, the percentages of lymphocytes in G3 were in-
creased in both CAV inoculated groups (p < 0.05). This in-
crease was higher in thymuses from CAV-10 inoculated
chickens with respect to the increase observed in thy-
muses from CAV-18 inoculated birds (p < 0.05).Figure 4 Histopathological findings of CAV infection in tissues from 4
infection with CAV or inoculation with PBS at 2 weeks of age, and pictures
groups stained with HE, 10× (a-f). (a) Thymus lobe from PBS inoculated gr
cortical lymphocyte depletion and absence of demarcation between the m
(d) bursa of Fabricius from the PBS inoculated group; (e) bursa of Fabricius fro
the follicles with follicular atrophy marked with an arrow; (f) bursa of Fabriciu
karyomegaly in thymuses from CAV-10 inoculated chickens, 40×; vacuolizationThe multiparametric analysis of CD3+ cells within the
G1 region revealed the presence of CD4 + CD8α-, CD4-
CD8α + and CD4 + CD8α + cell subsets. As shown in
Figure 6A, the predominant subset in the control thymus
was the double positive (DP) CD4 + CD8α+. Preliminary
data show that these DP cells also express CD8β on their
surface (data not shown), indicating that they are imma-
ture DP cells that did not undergo positive and negative
selection, a characteristic during ontogeny of T lympho-
cytes. These DP cells in G1 were then divided into two-week-old SPF chickens. Animals were studied 14 days after
show representative tissue samples from experimental and control
oup; (b) thymus lobe from CAV-10 inoculated group with severe
edulla and cortex; (c) thymus lobe from CAV-18 inoculated group;
m CAV-10 inoculated group, showing moderate lymphoid depletion of
s from the CAV-18 inoculated group. (g) Large lymphoblasts with

















































G1= 80.18 G1= 78.41G1= 74.56
G2= 61.22 G2= 48.87G2= 38.01
G3= 18.21 G3= 28.71G3= 36.07
Figure 5 Flow cytometry analysis of lymphocyte subpopulations in the thymus from CAV-10, CAV-18 and PBS inoculated chickens.
Animals were studied 14 days after infection with CAV or inoculation with PBS at 2 weeks of age. (a) Analysis was performed in G1 according to
forward/side scatter parameters. Thymocytes in G1 were divided into small (G2) and large (G3) cells; (b) Mean percentages of G1, G2 and G3 cells
in the thymus from control and CAV-inoculated groups. The results are expressed as the mean (SD) from each group, n = 6. *p < 0.05 vs. Control;
# p < 0.05 vs. CAV-18.
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surface expression of CD4 and CD8α. While thymocytes
in R4 have higher CD8α expression than thymocytes in
R5, thymocytes in R5 have higher CD4 expression than
cells in R4.
Figures 6B and 6C show DP cells from a thymus of the
control group in G2 and G3 respectively. Most of the
small DP with size and granularity compatible with G2
were in R4, whereas large DP cells from G3 were located
in both R4 and R5. In particular, CAV-10 not only re-
duced (p < 0.05) the percentages of total DP thymocytes
in G1, G2 and G3 as CAV-18 (Figure 6J-L), but alsoaltered the percentage of DP thymocytes in R4 and R5
(Figure 6D-I). CAV-10 in particular produced a higher
reduction of DP in R4 (in G1, G2 and G3) than CAV-18
(p < 0.05), and a particular significant increase of DP in
R5 (G1 and G2) that was not seen in thymuses from
CAV-18 inoculated chickens (Figure 6J-L).
Figures 6A, 6D and 6G also show some differences in
CD4 + CD8α- and CD4-CD8α + thymocytes in G1 be-
tween control, CAV-10 and CAV-18 inoculated groups.
Both CAV-inoculated groups appear to have increased
their CD4 + CD8α- and CD4-CD8α + subsets when

























































































































































































Figure 6 Analysis of different lymphocyte subpopulations in the thymus of SPF chickens. Animals were studied 14 days after infection
with CAV or inoculation with PBS at 2 weeks of age. (A-I) CD4 + CD8α-, CD4-CD8α + and CD4 + CD8α + (DP) thymocytes from one thymus from
each group in G1 (A, D, G), G2 (B, E, H) and G3 (C, F, I). R4 and R5 represent DP thymocytes with different CD4 and CD8α surface expression.
(J-L) Mean percentage of total DP, DP in R4 and DP in R5 thymocytes in G1, G2 and G3 from control (□), CAV-10 (■) and CAV-18 ( ) birds. (M)
Mean absolute number of CD4 + CD8α- and CD4-CD8α + thymocytes in G1 from control (□), CAV-10 (■) and CAV-18 ( ) birds. Cells were
triple-labeled with anti-CD3, anti-CD4 and anti-CD8α antibodies conjugated to SPRD, FITC and PE, respectively, and analyzed by flow cytometry.
The results are expressed as the mean (SD) from each group, n = 6. *p < 0.05 vs. Control; # p < 0.05 vs. CAV-18.
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thymocyte subpopulations were compared between
groups, only the number of CD4-CD8α + thymocytes were
reduced in thymuses from CAV-10 inoculated chickens
(p < 0.05) (Figure 6M).
Analysis of splenic cell subpopulations
Splenic lymphocytes from experimental groups were ana-
lyzed in G1 according to forward/side scatter parameters.
Staining with CD3/CD4/CD8α
The analysis revealed the presence of CD3 + CD4 +
CD8α- (ThL), CD3 +CD4-CD8α + (CTL) and CD3 +
CD4 +CD8α + (mature DP) cell subsets. Figure 7a shows
that mature DP cells from spleen were in R5, indicating
that there was a unique DP subset that represents a par-
ticular splenic population. These mature DP cells were
not significantly altered at 14 dpi with Argentinean
CAV strains (Figure 7b). Similar results were obtained
for splenic ThL cells, which did not significantly differ
between groups. However, the CTL subset decreased
only in chickens inoculated with CAV-10 (p < 0.05).
Staining with CD3/CD8α/CD8β
The G1 region revealed the presence of splenic CD8
lymphocytes, either CD8αα or CD8αβ cell subsets. The
percentages of splenic CD8αα cells did not significantlydiffered between groups, although a small increase was
observed in CAV-10 inoculated chickens (Figure 8). In
contrast, the number of CTL CD8αβ was reduced in
chickens inoculated with CAV-10 (p < 0.05).
Serological testing
Before inoculation, 3 chickens per group were bled, and
all of them were negative to antibodies against CAV. At
14 dpi, seroconversion of animals inoculated with CAV-10
and CAV-18 was monitored. All chickens from CAV-10
and CAV-18 inoculated groups were positive for anti-CAV
antibodies (S/N ratio ≤ 0.6), whereas birds from the
control group remained negative (S/N ratio > 0.6). At
this time post-infection no significant differences in
CAV-specific antibody levels could be detected between
CAV-10 and CAV-18 inoculated groups (Figure 9).
Discussion
Complete genome sequencing and comparison of CAV-
10 and CAV-18 viruses showed few differences between
these two Argentinean strains. Both CAV strains have a
deletion that contained a fifth 19-nt repeat, with this re-
gion being associated with a better efficiency to replicate
in MDCC-MSB1 cell cultures [31]. However, previous
reports affirmed that the contribution of this region to


















































Figure 7 Flow cytometry analysis of CD4 + CD8α-, CD4-CD8α + and CD4 + CD8α + (DP) splenocytes of SPF chickens. (a) Analysis was
performed in G1 according to forward/side scatter parameters. Most double positive splenocytes were in R5 according to their CD4 and CD8α
surface expression. (b) Mean percentage of splenocyte subpopulations from control (□), CAV-10 (■) and CAV-18 ( ) birds. Cells were
triple-labelled with anti-CD3, anti-CD4 and anti-CD8α antibodies conjugated to SPRD, FITC and PE, respectively, and analysed by flow cytometry.
The results are expressed as the mean (SD) from each group, n = 6. *p < 0.05 vs. Control.
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CAV-10 and CAV-18 confirmed that both viruses present
mutations in the hypervariable region of VP1 that are also
associated with a reduced spread in an avian lymphoblas-
toid cell line (MDCC-MSB1) compared with Cux-1 [26].
However, these authors were unable to demonstrate dif-
ferences in host pathogenesis in vivo due to differences in
this region. On the contrary, Meehan et al. [24] have
shown that this region does not contribute disproportion-
ately to pathogenicity compared to other regions through-
out the genome, and that alterations in more than one of
the three CAV proteins, as well as in the noncoding region
of the genome, may influence pathogenicity.
Despite the eleven nucleotide differences observed
along VP1, only two deduced amino acid substitutions
were seen in CAV-10 with respect to the CAV-18 virus.
To our knowledge, there are still no reports about the
plausible role or the way in which these differences mayaffect the pathogenesis of CAV in the chicken. We be-
lieve that this report could be the first approach to
evaluate these amino acid differences of VP1 in vivo,
moreover taking into account the few nucleotide varia-
tions between CAV-10 and CAV-18 observed only in the
non-coding region. However, under our experimental
conditions we cannot ensure that the same dosage of
each isolate was administered in chickens. Therefore,
further studies should be performed to calculate infectiv-
ity titres of these field strains in vitro to associate gen-
omic differences between Argentinean CAV strains with
different pathogenicities in vivo.
In the present study chickens infected either with
CAV-10 or CAV-18 did not present clinical signs of dis-
ease throughout the experiment. However, both groups
inoculated with Argentinean CAV strains experimented
a significant reduction of thymus-to-body weight ratios


























Figure 8 Analysis of CD3 + CD8αα + and CD3 + CD8αβ +
splenocytes of SPF chickens. Analysis was performed in G1
according to forward/side scatter parameters. Splenocyte
subpopulations from control (□), CAV-10 (■) and CAV-18 ( )
birds were triple-labelled with anti-CD3, anti-CD8α and anti-CD8β
antibodies conjugated to SPRD, FITC and PE, respectively, and
analysed by flow cytometry. The results are expressed as the
mean (SD) from each group, n = 6. *p < 0.05 vs. Control.
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http://www.veterinaryresearch.org/content/45/1/102CAV-18) and thymocyte depletion at 14 dpi. These re-
sults suggest that both CAV field strains produce a sub-
clinical infection in 2-week-old birds.
In addition, chickens infected with CAV-10 virus also
show histopathological lesions in the thymus and bursa,
compatible with those previously reported by Haridy
et al. [32] in subclinical infections with CAV. It is im-
portant to mention that these authors infected animals

















Figure 9 Specific antibody levels against CAV after 14 days
post-infection with Argentinean CAV strains in 2-week-old
chickens. Optical densities obtained were expressed as signal to
noise ratios. The results are expressed as the mean (SD) from each
group, n = 6. *p < 0.05 vs. Control.times in MDCC-MSB1 cells [33], where mutations could
be introduced. By contrast, CAV-18 inoculated chickens
did not present obvious morphological changes in the
evaluated organs. This might suggest that alteration of
functionality was not very strong or that their course
was produced in a very short time in this group and,
consequently, the morphological changes could not be
observed throughout a histopathological study. There-
fore, differences in histopathological lesions produced by
CAV-10 or CAV-18 in 2-week-old chickens might sug-
gest that CAV-10 is more aggressive than CAV-18 after
in vivo infection, at least at this time post-infection.
Flow cytometry analysis of thymocytes in G1, G2 and
G3 from CAV-inoculated chickens vs. control group ani-
mals suggests that Argentinean CAV strains alter the
thymocyte maturation process after 14 dpi.
The most evident variation was the reduction observed
in DP thymocytes following CAV inoculation. Similar re-
sults were published by Vaziry et al. [21] and Hu et al.
[20], evaluating the lesions in 1-day-old chicks infected
with the CIA-1 strain. In addition, our results clearly
demonstrate that there are different stages of maturation
of DP cells due to thymopoiesis in the thymus, and that
some of these stages could be altered after CAV infec-
tion. While DP in R4 significantly decreased after CAV
infection, DP in R5 significantly increased. These evident
changes in the percentages of DP thymocytes with differ-
ent CD4 and CD8α surface expression support the idea
that Argentinean CAV viruses can alter thymopoiesis.
Even more, under our experimental conditions, CAV-10
produced significantly deeper alterations than CAV-18
in thymocyte maturation two weeks after infection.
On the contrary, the reduction in the total number of
lymphocytes in thymuses from CAV inoculated chickens
observed during the cell isolation procedure, the absence
of significant changes in the number of CD4 + CD8α-
thymocytes and the slight decrease of CD4-CD8α + cells
observed after flow cytometry analysis of the thymic
population add to the notion that mature lymphocytes
were not recruited into the thymus at 14 dpi with Ar-
gentinean CAV strains. These results were in concord-
ance with previous observations by Vaziry et al. [21] in a
subclinical infection with a vaccinal strain.
Finally, the alterations in percentages of splenic lympho-
cyte subpopulations were also analyzed by flow cytometry.
There were no differences in mature DP and ThL cells
between groups after infection with Argentinean field
strains, similar to results previously published by other
authors with the CIA-1 vaccinal strain [21]. However, in
our experimental infection, CTL cells were statistically
reduced in spleens from CAV-10 inoculated chickens.
Moreover, staining with CD3, CD8α and CD8β mAb
allowed discrimination between CD8+ subsets (CD8αα
or CD8αβ) that were affected by CAV inoculation. While
Rimondi et al. Veterinary Research 2014, 45:102 Page 11 of 12
http://www.veterinaryresearch.org/content/45/1/102our results show no differences in CD8αα cells, significant
reduction in percentages of the CD8αβ subpopulation was
observed only in CAV-10 inoculated birds. Adair et al.
[22] have demonstrated the presence of infected mature
lymphocytes in the spleen after 6 dpi, although the
numbers of infected cells as a proportion of the total
number recorded was much lower than that in the thy-
mus or bone marrow. Our results, where a significant
decrease in splenic CD8αβ lymphocytes was observed at
14 dpi, could be the consequence of the large amount of
CAV-infected splenocytes reported by Adair et al. at a
previous time post-infection. Altogether, our results
suggest that CAV-10 affects splenic lymphocyte subpopu-
lations by a reduction in CD8αβ subset and, consequently,
this could alter the host immune response against other
secondary pathogens.
In this work we studied the subclinical infection of
2-week-old chickens with two Argentinean CAV field
strains, showing some nucleotide differences in their
genome sequence. Under our experimental conditions,
the results might suggest there are differences in the be-
havior of CAV-10 and CAV-18 strains in vivo at 14 dpi.
Further studies should be done to determine first the viral
titer of these CAV field strains and then, to associate nu-
cleotide/amino acidic composition, in VP1 and/or in non-
coding region, with differential pathogenicity in chickens.
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